Krka (KRKG)

Currency in EUR
255.00
-1.00(-0.39%)
Closed·
KRKG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
253.00256.00
52 wk Range
174.00260.00
Key Statistics
Bid/Ask
255.00 / 255.00
Prev. Close
256
Open
256
Day's Range
253-256
52 wk Range
174-260
Volume
1.78K
Average Volume (3m)
3.76K
1-Year Change
38.9646%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KRKG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
210.73
Downside
-17.36%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 19 consecutive years

Krka News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Analyst Ratings

3 Buy
2 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 210.73
(-17.36% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 13, 2026
EPS / Forecast
3.69 / --
Revenue / Forecast
565.77M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 11.98%
Dividend Yield
3.55%
Industry Median 3.42%
Annualized payout
9.10
Paid annually
5-Years Growth
+12.72%
Growth Streak

KRKG Income Statement

Compare KRKG to Peers and Sector

Metrics to compare
KRKG
Peers
Sector
Relationship
P/E Ratio
20.9x17.5x−0.5x
PEG Ratio
−2.010.120.00
Price/Book
3.2x1.6x2.6x
Price / LTM Sales
3.7x1.4x3.1x
Upside (Analyst Target)
−16.3%6.0%53.2%
Fair Value Upside
Unlock13.5%6.2%Unlock

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabolism, and other therapeutic areas, as well as analgesics, vitamins, minerals, and vasoprotectives. In addition, the company offers animal health products, including antiparasitics, antimicrobials, and other products. Further, it provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.

Employees
11667
Market
Slovenia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
885.52K2.92%226.69M
Other Institutional Investors
12.85M42.41%3.29B
Public Companies & Retail Investors
16.57M54.67%4.24B
Total
30.31M100.00%7.76B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kapitalska družba pokojninskega in invalidskega zavarovanja, d. d.11.52%3,493,030894,216
Slovenian Sovereign Holding, d.d.9.73%2,949,876755,168

People Also Watch

96.60
LKPG
0.00%
53.20
PETG
-0.75%
146.5000
PRY
-2.53%
68.20
ZVTG
-0.29%

FAQ

What Is the Krka (KRKG) Stock Price Today?

The Krka stock price today is 255.00 EUR.

What Stock Exchange Does Krka Trade On?

Krka is listed and trades on the Ljubljana Stock Exchange.

What Is the Stock Symbol for Krka?

The stock symbol for Krka is "KRKG."

Does Krka Pay Dividends? What’s The Current Dividend Yield?

The Krka dividend yield is 3.53%.

What Is the Krka Market Cap?

As of today, Krka market cap is 7.76B EUR.

What Is Krka's Earnings Per Share (TTM)?

The Krka EPS (TTM) is 11.98.

When Is the Next Krka Earnings Date?

Krka will release its next earnings report on Jul 23, 2026.

From a Technical Analysis Perspective, Is KRKG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Krka Stock Split?

Krka has split 1 times.

How Many Employees Does Krka Have?

Krka has 11667 employees.

What is the current trading status of Krka (KRKG)?

As of May 27, 2026, Krka (KRKG) is trading at a price of 255.00 EUR, with a previous close of 256.00 EUR. The stock has fluctuated within a day range of 253.00 EUR to 256.00 EUR, while its 52-week range spans from 174.00 EUR to 260.00 EUR.

What Is Krka (KRKG) Price Target According to Analysts?

The average 12-month price target for Krka is 210.73 EUR, with a high estimate of 290 EUR and a low estimate of 115 EUR. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -17.36% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.